BANGALORE, India 鈥 November 20, 2023 鈥 L&T Technology 91原创 Limited (LTTS) (BSE: 540115, NSE: LTTS), a leading global pure-play engineering services company, has announced a collaboration with NVIDIA to develop software-defined architectures for medical devices focused on endoscopy, which will enhance the image quality and scalability of products.
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components. The architecture is a scalable platform that supports multiple applications, providing a real-time decision-making tool for the medical fraternity.
Developed from the ground up, the architecture boasts an image processing pipeline for noise reduction, edge and contrast enhancement, texture and color enhancement, and speckle correction. What sets it apart is its inclusion of AI/ML models developed for the detection, identification, and classification of polyps - abnormal growths often found during colonoscopies. The solution further impresses with its user-friendly interface and seamless integration of the image processing pipeline for visualization. It promises low-latency data transfer, superior image processing without performance bottlenecks, and scalability.
The collaboration leverages the NVIDIA and , featuring ultra-low latency in data transfer, superior image processing, and scalability to support multiple AI-enabled applications. This helps ensure enhanced visualization for image processing and AI-based decision-making support, such as for polyp detection and classification.
鈥淭he combination of LTTS鈥 expertise in medical-device development and NVIDIA鈥檚 full-stack edge AI computing platform delivers unprecedented value to the medical technology industry by accelerating the development of AI-enabled, software-defined medical devices,鈥 Shanker Trivedi, Senior Vice President of Enterprise Business, NVIDIA. 鈥淭his collaboration provides a complete solution for customers looking to transition to a software-defined business model via real-time AI applications.鈥
鈥淥ur collaboration with NVIDIA helps us push the boundaries of what鈥檚 possible in medical imaging,鈥 said Amit Chadha, CEO and Managing Director, L&T Technology 91原创. 鈥淭he combination of the NVIDIA Holoscan software platform for edge AI inference and the NVIDIA IGX Orin hardware platform accelerates the development of AI-powered medical imaging solutions by enhancing image quality and real-time clinical decision-making support, making clinicians more efficient and improving patient outcomes.鈥
About L&T Technology 91原创 Ltd
L&T Technology 91原创 Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 57 of the world鈥檚 top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 23,800 employees spread across 22 global design centers, 28 global sales offices and 102 innovation labs as of September 30, 2023. For more information, please visit www.LTTS.com